Loading
Short/Intermediate-acting·Neurology - Sedatives & Hypnotics
Acute agitation, status epilepticus, short-term anxiety, alcohol withdrawal in hepatic impairment
Max Dose
4 mg/day
Half-life
10-20 h
Hepatic Safe
L.O.T. DRUG
Dependence
HIGH RISK
Overview
Intermediate-acting benzodiazepine. Does not require hepatic phase 1 metabolism, making it highly predictable and incredibly safe for the elderly and those with liver failure.
Maximum Dose
Max 4 mg/day (Usually given in 0.5 - 1 mg doses).
Clinical Focus
The drug of choice for acute seizures or severe agitation in patients with end-stage liver cirrhosis.
Bottom Line
Lorazepam is the preferred benzodiazepine in hepatic impairment and status epilepticus (no active metabolites), but causes significant sedation and respiratory depression, and is highly dependency-forming.
Brand Names
Ativan
Oral Routes
Tablets (1 mg, 2.5 mg). Can be dissolved sublingually.
Parenteral
Ampoules for IV / IM use. (Unlike Diazepam, IM absorption is excellent and predictable).
Prescribing & PBS
Authority Required (PBS).
Primary
Acute agitation, status epilepticus, short-term anxiety, alcohol withdrawal in hepatic impairment.
Clinical Place
Highly versatile. Binds tightly to the receptor, providing longer clinical effect than its half-life suggests.